Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ISRCTN13257145) titled 'Mineralised drinking water to improve diabetes and high blood pressure control in Bangladesh' on Dec. 22, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Open (masking not used)
Control: Placebo
Assignment: Single
Purpose: Treatment
Primary Sponsor: Aquanimity Bangladesh Ltd
Condition:
1. Aged 30-60 years
2. Diagnosed with uncontrolled or poorly controlled type 2 diabetes (HbA1c >8.0%, or fasting plasma glucose =10 mmol/L, or 2-hour post-breakfast glucose =12 mmol/L)
3. Diagnosed with uncontrolled hypertension (SBP >140 mmHg or DBP >90 mmHg)
4. On stable oral ant...